Elastic modulus-based thrombelastographic quantification of plasma clot fibrinolysis with progressive plasminogen activation

Vance G Nielsen, Benjamin M. Cohen, Eli Cohen

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Thrombelastographic detection of fibrinolysis has been critical in the identification and treatment of coagulopathy in many perioperative settings. However, the fibrinolytic assessments have been at best non-parametric, amplitude-based determinations (e.g. estimated % lysis, clot lysis time or clot lysis rate). Recognizing this limitation, a methodology was developed to measure the onset, speed and extent of clot disintegration by changes in elastic modulus derived from the amplitude. Using this approach, our goal was to characterize the clot disintegration kinetics of progressive plasminogen activation with tissue plasminogen activator (tPA) and to determine the extent of inhibition of fibrinolysis mediated by tPA with aprotinin and activated factor XIII. While the estimated % lysis and clot lysis time were significantly affected by tPA (0-300 U/ml), elastic modulus-based analyses in a more activity-specific fashion demonstrated significantly decreased onset, increased rate and increased extent of fibrinolysis. Furthermore, aprotinin was found to inhibit the onset, rate and extent of fibrinolysis in an activity-dependent fashion, whereas activated factor XIII was noted to enhance the speed of onset of clot growth and delay the onset of fibrinolysis. In summary, our results serve as the rational basis to utilize this elastic modulus-based approach to quantify the extent of fibrinolysis in clinical and laboratory settings, as well as potentially guiding antifibrinolytic therapy.

Original languageEnglish (US)
Pages (from-to)75-81
Number of pages7
JournalBlood Coagulation and Fibrinolysis
Volume17
Issue number1
StatePublished - Jan 2006
Externally publishedYes

Fingerprint

Elastic Modulus
Plasminogen
Fibrinolysis
Tissue Plasminogen Activator
Fibrin Clot Lysis Time
Factor XIIIa
Aprotinin
Antifibrinolytic Agents
Growth

Keywords

  • Aprotinin
  • Coagulation
  • Factor XIII
  • Fibrinolysis
  • Monitoring
  • Thrombelastography
  • Tissue plasminogen activator

ASJC Scopus subject areas

  • Hematology

Cite this

Elastic modulus-based thrombelastographic quantification of plasma clot fibrinolysis with progressive plasminogen activation. / Nielsen, Vance G; Cohen, Benjamin M.; Cohen, Eli.

In: Blood Coagulation and Fibrinolysis, Vol. 17, No. 1, 01.2006, p. 75-81.

Research output: Contribution to journalArticle

@article{0bb8c57aee3743368f5b42830d78af59,
title = "Elastic modulus-based thrombelastographic quantification of plasma clot fibrinolysis with progressive plasminogen activation",
abstract = "Thrombelastographic detection of fibrinolysis has been critical in the identification and treatment of coagulopathy in many perioperative settings. However, the fibrinolytic assessments have been at best non-parametric, amplitude-based determinations (e.g. estimated {\%} lysis, clot lysis time or clot lysis rate). Recognizing this limitation, a methodology was developed to measure the onset, speed and extent of clot disintegration by changes in elastic modulus derived from the amplitude. Using this approach, our goal was to characterize the clot disintegration kinetics of progressive plasminogen activation with tissue plasminogen activator (tPA) and to determine the extent of inhibition of fibrinolysis mediated by tPA with aprotinin and activated factor XIII. While the estimated {\%} lysis and clot lysis time were significantly affected by tPA (0-300 U/ml), elastic modulus-based analyses in a more activity-specific fashion demonstrated significantly decreased onset, increased rate and increased extent of fibrinolysis. Furthermore, aprotinin was found to inhibit the onset, rate and extent of fibrinolysis in an activity-dependent fashion, whereas activated factor XIII was noted to enhance the speed of onset of clot growth and delay the onset of fibrinolysis. In summary, our results serve as the rational basis to utilize this elastic modulus-based approach to quantify the extent of fibrinolysis in clinical and laboratory settings, as well as potentially guiding antifibrinolytic therapy.",
keywords = "Aprotinin, Coagulation, Factor XIII, Fibrinolysis, Monitoring, Thrombelastography, Tissue plasminogen activator",
author = "Nielsen, {Vance G} and Cohen, {Benjamin M.} and Eli Cohen",
year = "2006",
month = "1",
language = "English (US)",
volume = "17",
pages = "75--81",
journal = "Blood Coagulation and Fibrinolysis",
issn = "0957-5235",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Elastic modulus-based thrombelastographic quantification of plasma clot fibrinolysis with progressive plasminogen activation

AU - Nielsen, Vance G

AU - Cohen, Benjamin M.

AU - Cohen, Eli

PY - 2006/1

Y1 - 2006/1

N2 - Thrombelastographic detection of fibrinolysis has been critical in the identification and treatment of coagulopathy in many perioperative settings. However, the fibrinolytic assessments have been at best non-parametric, amplitude-based determinations (e.g. estimated % lysis, clot lysis time or clot lysis rate). Recognizing this limitation, a methodology was developed to measure the onset, speed and extent of clot disintegration by changes in elastic modulus derived from the amplitude. Using this approach, our goal was to characterize the clot disintegration kinetics of progressive plasminogen activation with tissue plasminogen activator (tPA) and to determine the extent of inhibition of fibrinolysis mediated by tPA with aprotinin and activated factor XIII. While the estimated % lysis and clot lysis time were significantly affected by tPA (0-300 U/ml), elastic modulus-based analyses in a more activity-specific fashion demonstrated significantly decreased onset, increased rate and increased extent of fibrinolysis. Furthermore, aprotinin was found to inhibit the onset, rate and extent of fibrinolysis in an activity-dependent fashion, whereas activated factor XIII was noted to enhance the speed of onset of clot growth and delay the onset of fibrinolysis. In summary, our results serve as the rational basis to utilize this elastic modulus-based approach to quantify the extent of fibrinolysis in clinical and laboratory settings, as well as potentially guiding antifibrinolytic therapy.

AB - Thrombelastographic detection of fibrinolysis has been critical in the identification and treatment of coagulopathy in many perioperative settings. However, the fibrinolytic assessments have been at best non-parametric, amplitude-based determinations (e.g. estimated % lysis, clot lysis time or clot lysis rate). Recognizing this limitation, a methodology was developed to measure the onset, speed and extent of clot disintegration by changes in elastic modulus derived from the amplitude. Using this approach, our goal was to characterize the clot disintegration kinetics of progressive plasminogen activation with tissue plasminogen activator (tPA) and to determine the extent of inhibition of fibrinolysis mediated by tPA with aprotinin and activated factor XIII. While the estimated % lysis and clot lysis time were significantly affected by tPA (0-300 U/ml), elastic modulus-based analyses in a more activity-specific fashion demonstrated significantly decreased onset, increased rate and increased extent of fibrinolysis. Furthermore, aprotinin was found to inhibit the onset, rate and extent of fibrinolysis in an activity-dependent fashion, whereas activated factor XIII was noted to enhance the speed of onset of clot growth and delay the onset of fibrinolysis. In summary, our results serve as the rational basis to utilize this elastic modulus-based approach to quantify the extent of fibrinolysis in clinical and laboratory settings, as well as potentially guiding antifibrinolytic therapy.

KW - Aprotinin

KW - Coagulation

KW - Factor XIII

KW - Fibrinolysis

KW - Monitoring

KW - Thrombelastography

KW - Tissue plasminogen activator

UR - http://www.scopus.com/inward/record.url?scp=31644436226&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31644436226&partnerID=8YFLogxK

M3 - Article

C2 - 16607085

AN - SCOPUS:31644436226

VL - 17

SP - 75

EP - 81

JO - Blood Coagulation and Fibrinolysis

JF - Blood Coagulation and Fibrinolysis

SN - 0957-5235

IS - 1

ER -